Effecf of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: A randomized, double-blind, placebo-controlled study

Aging Clinical and Experimental Research

Volumn 21, Issue 1, 2009, Pages 38-42

  Garzón, Cristina ^a   Guerrero, Juan M ^b   Aramburu, Oscar ^a   Guzmán, Tomás ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Behavioural disorders; Elderly; Melatonin; Sleep disorders

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT; MELATONIN; PLACEBO; HYPNOTIC SEDATIVE AGENT;

AGED; ANXIETY; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FEMALE; GERIATRIC DEPRESSION SCALE; GERIATRIC PATIENT; HUMAN; INSOMNIA; MALE; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; BEHAVIOR; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

AGED; AGED, 80 AND OVER; ANXIETY; BEHAVIORAL SYMPTOMS; CROSS-OVER STUDIES; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MELATONIN; SLEEP DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 62649174879     PISSN: 15940667     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03324897     Document Type: Article

References (38)

1. Ancoli-Israel S, Cooke JR. Prevalence and comorbidity of insomnia and effect on functioning in elderly populations. J Am Geriatr Soc 2005; 53: S264-71.
2. Buysse DJ. Insomnia, depression and aging. Assessing sleep and mood interactions in older adults. Geriatrics 2004; 59: 47-51.
3. Taylor DJ. Lichstein KL. Durrence HH et al. Epidemiology of insomnia, depression, and anxiety. Sleep 2005; 28: 1457-64.
4. Ried LD, Johnson RE, Gettman DA. Benzodiazepine exposure and functional status in older people. J Am Geriatr Soc 1998; 46: 71-6.
5. Rajput V, Bromley SM. Chronic insomnia: a practical review. Am Fam Physician 1999; 60: 1431-8.
6. McCall WV. Diagnosis and management of insomnia in older people. J Am Geriatr Soc 2005; 53: S272-7.
7. Yoon IY, Kripke DF, Elliott JA et al. Age-related changes of circadian rhythms and sleep-wake cycles. J Am Geriatr Soc 2003; 51: 1085-91.
8. Monk TH. Aging human circadian rhythms: conventional wisdom may not always be right. J Biol Rhythms 2005; 20: 366-74.
9. Lavie P. Melatonin: role in gating nocturnal rise in sleep propensity. J Biol Rhythms 1997; 12: 657-65.
10. Cajochen C, Krauchi K, Wirz-Justice A. Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol 2003; 15: 432-7.
11. Dollins AB, Zhdanova IV, Wurtman RJ et al. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci USA 1994; 91: 1824-8.
12. Arendt J, Skene DJ. Melatonin as a chronobiotic. Sleep Med Rev 2005; 9: 25-39.
13. Garfinkel D, Laudon M, Nof D et al. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995; 346: 541-4.
14. Garfinkel D, Laudon M, Zisapel N. Improvement of sleep quality by controlled-release melatonin in benzodiazepine-treated elderly insomniacs. Arch Gerontol Geriatr 1997; 24: 223-31.
15. Hughes RJ, Sack RL, Lewy AJ. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement. Sleep 1998; 21: 52-68.
16. Zhdanova IV, Wurtman RJ, Regan MM et al. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab 2001; 86: 4727-30.
17. Leger D, Laudon M, Zisapel N. Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. Am J Med 2004; 116: 91-5.
18. Sack RL, Lewy AJ, Erb DL et al. Human melatonin production decreases with age. J Pineal Res 1986; 3: 379-88.
19. Benot S, Goberna R, Reiter RJ et al. Physiological levels of melatonin contribute to the antioxidant capacity of human serum. J Pineal Res 1999; 27: 59-64.
20. Garfinkel D, Zisapel N, Wainstein J et al. Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach. Arch Intern Med 1999; 159: 2456-60.
21. Siegrist C, Benedetti C, Orlando A et al. Lack of changes in serum prolactin, FSH, TSH, and estradiol after melatonin treatment in doses that improve sleep and reduce benzodiazepine consumption in sleep-disturbed, middle-aged, and elderly patients. J Pineal Res 2001; 30: 34-42.
22. Brzezinski A, Vangel MG, Wurtmann RJ et al. Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev 2005; 9: 41-50.
23. Buscemi N, Vandermeer B, Hooton N et al. The efficacy and safety of exogenous melatonin for primary sleep disorders: A meta-analysis. J Gen Intern Med 2005; 20: 1151-8.
24. The Northside Hospital Sleep Medicine Institute Test. Available at http://www.nshsleep.com/test.cfm. Accessed February 20, 2006.
25. Yesavage JA, Brink TL, Rose TL et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982-83; 17: 37-49.
26. Goldberg D, Bridges K, Duncan-Jones P et al. Detecting anxiety and depression in general medical settings. BMJ 1988; 297: 897-9.
27. Gorfine T, Assaf Y, Goshen-Gottstein Y et al. Sleep-anticipating effects of melatonin in the human brain. Neuroimage 2006; 31: 410-8.
28. Haimov I, Lavie P, Laudon M et al. Melatonin replacement therapy of elderly insomniacs. Sleep 1995; 18: 598-603.
29. Jean-Louis G, von Gizycki H, Zizi F. Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment. J Pineal Res 1998; 25: 177-83.
30. Leppamaki S, Partonen T, Vakkuri O et al. Effect of controlled-release melatonin on sleep quality, mood, and quality of life in subjects with seasonal or weather-associated changes in mood and behaviour. Eur Neuropsychopharmacol 2003; 13: 137-45.
31. Almeida Montes LG, Ontiveros Uribe MP, Cortes Sotres J et al. Treatment of primary insomnia with melatonin: a double-blind, placebo-controlled, crossover study. J Psychiatry Neurosci 2003; 28: 191-6.
32. Dolberg OT, Hirschmann S, Grunhaus L. Melatonin for the treatment of sleep disturbances in major depressive disorder. Am J Psychiatry 1998; 155: 1119-21.
33. Buscemi N, Vandermeer B, Hooton N et al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ 2006; 332: 385-93.
34. Cardinali DP, Gvozdenovich E, Kaplan MR et al. A double blind-placebo controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly. Neuroendocrinol Lett 2002; 23: 55-60.
35. Frels C, Williams P, Narayanan S et al. Iatrogenic causes of falls in hospitalised elderly patients: a case-control study. Postgrad Med J 2002; 78: 487-9.
36. Landi F, Onder G, Cesari M et al. Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci 2005; 60: 622-6.
37. Dalton EJ, Rotondi D, Levitan RD et al. Use of slow-release melatonin in treatment-resistant depression. J Psychiatry Neurosci 2000; 25: 48-52.
38. Seabra ML, Bignotto M, Pinto LB Jr et al. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res 2000; 29: 193-200.